FIELD: chemistry.
SUBSTANCE: invention relates to conjugates, in particular presented is nicotine hapten-carrier of formula (III): W represents -O- and is in position 5 of pyridine ring; -(spacer)- represents C1-C8alkylene group, C3-C10cycloalkylene group or C1-C12alkylene group, interrupted by 1-4 oxygen atoms and possibly interrupted by group -N(H)C(O)-; X* represents -NH- or -S-; m stands for 1; n stands for integer number from 1 to 1000; and Y represents possibly modified carrier protein, selected from bacterial anatoxins, immunogenic substances, viruses, virus-like particles, protein complexes, proteins, polypeptides, liposomes and immunostimulating complexes, which can be used for preparation of vaccines for treatment and/or prevention of nicotine dependence.
EFFECT: obtaining compounds which can be used for preparation of vaccines for treatment and/or prevention of nicotine dependence.
8 cl, 23 dwg, 7 tbl, 22 ex
Title | Year | Author | Number |
---|---|---|---|
PNEUMOCOCCAL VACCINE AND USING IT | 2010 |
|
RU2536248C2 |
HAPTEN-CARRIER CONJUGATES AND APPLICATION | 2003 |
|
RU2326693C2 |
IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCUS VACCINES | 2016 |
|
RU2712622C2 |
COMBINED VACCINES WITH WHOLE CELL PERTUSSIS ANTIGEN | 2006 |
|
RU2420315C2 |
CH3 IGE PEPTIDE VACCINE | 2009 |
|
RU2495049C2 |
MENINGOCOCCAL CONJUGATE VACCINATION | 2005 |
|
RU2379052C2 |
IMMUNOSTIMULATING OLIGONUCLEOTIDES | 2009 |
|
RU2477753C2 |
IMMUNOSTIMULATORY OLIGONUCLEOTIDES | 2012 |
|
RU2610690C2 |
PNEUMOCOCCAL POLYSACCHARIDES AND THEIR USE IN POLYSACCHARIDE-PROTEIN-CARRIER IMMUNOGENIC CONJUGATES | 2018 |
|
RU2801288C2 |
CONJUGATES OF STREPTOCOCCUS POLYSACCHARIDE GROUP B AND PROTEIN, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS CONTAINING CONJUGATES, AND THEIR USE | 2016 |
|
RU2692923C2 |
Authors
Dates
2016-01-27—Published
2011-06-03—Filed